Sources Jiang Y, et al
Veterans with obesity report poorer health status and more disability days compared to veterans without obesity
In the first study, the authors did not find any significant difference in biochemical hyperandrogenism in both intra and inter-groups, despite the significant improvement in anthropometric parameters in the group treated with liraglutide [57]
List of GLP-1 ini6al approvals since 2005 *products no longer on the market Notable GLP-1 Agonists for Obesity The first GLP-1 drug approved for obesity was Saxenda (liraglutide) from Novo Nordisk, a twice-daily injectable that demonstrated a 7% weight reduction over a year upon its approval
Abbreviations 3D: Three-dimensional DARPin: Designed ankyrin repeat protein ECD: Extracellular domain GLP-1: Glucagon like peptide-1 GR: Gyration radius HSA: Human serum albumin MD: Molecular dynamics RMSD: Root mean square deviation RMSF: Root mean square fluctuation SASA: Solvent-accessible surface area T2DM: Type 2 diabetes mellitus References Piero, M., Nzaro, G
"If scripts are going in the right direction, and you're seeing the continued gains, my guess is people will look through any sort of choppiness around [the first or second quarter]," Gould said
